Revised SPC: Ibrance (palbociclib) tablets
Cutaneous lupus erythematosus has been added as an uncommon potential adverse effect of treatment.
Source:
electronic Medicines compendium
Cutaneous lupus erythematosus has been added as an uncommon potential adverse effect of treatment.
electronic Medicines compendium